Interestingly, miR222 has been shown to impact glucose uptake in mature adipocytes by regulating the expressions of estrogen receptor ERα and insulin-sensitive membrane transporter GLUT4, suggesting its potential as both a biomarker and therapeutic target for GDM [87]. This evidence concerns the gene ESR1 and gestational diabetes.